DE3578647D1 - Paramagnetische kontrastmittel fuer die anwendung in "in vivo" nmr-diagnostischen methoden und die herstellung davon. - Google Patents
Paramagnetische kontrastmittel fuer die anwendung in "in vivo" nmr-diagnostischen methoden und die herstellung davon.Info
- Publication number
- DE3578647D1 DE3578647D1 DE8585307737T DE3578647T DE3578647D1 DE 3578647 D1 DE3578647 D1 DE 3578647D1 DE 8585307737 T DE8585307737 T DE 8585307737T DE 3578647 T DE3578647 T DE 3578647T DE 3578647 D1 DE3578647 D1 DE 3578647D1
- Authority
- DE
- Germany
- Prior art keywords
- vivo
- production
- contrast agents
- diagnostic methods
- paramagnetic contrast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/12—Macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/12—Macromolecular compounds
- A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/806—Electrical property or magnetic property
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8405499A SE465907B (sv) | 1984-11-01 | 1984-11-01 | Diagnosticeringsmedel innehaallande en paramagnetisk metall |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3578647D1 true DE3578647D1 (de) | 1990-08-16 |
Family
ID=20357592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8585307737T Expired - Fee Related DE3578647D1 (de) | 1984-11-01 | 1985-10-25 | Paramagnetische kontrastmittel fuer die anwendung in "in vivo" nmr-diagnostischen methoden und die herstellung davon. |
Country Status (8)
Country | Link |
---|---|
US (1) | US4986980A (de) |
EP (1) | EP0186947B1 (de) |
JP (1) | JPH0667854B2 (de) |
AT (1) | ATE54416T1 (de) |
DE (1) | DE3578647D1 (de) |
DK (1) | DK167998B1 (de) |
NO (1) | NO168928C (de) |
SE (1) | SE465907B (de) |
Families Citing this family (103)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4735796A (en) * | 1983-12-08 | 1988-04-05 | Gordon Robert T | Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease |
EP0330801A1 (de) * | 1983-02-08 | 1989-09-06 | Schering Aktiengesellschaft | Ferromagnetische, diamagnetische oder paramagnetische Partikel, die in der Diagnose und Behandlung von Krankheiten nützlich sind |
DE3324235A1 (de) * | 1983-07-01 | 1985-01-10 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue komplexbildner, komplexe und komplexsalze |
SE463651B (sv) * | 1983-12-21 | 1991-01-07 | Nycomed As | Diagnostikum och kontrastmedel |
US6203777B1 (en) * | 1983-12-21 | 2001-03-20 | Nycomed Imaging As | Method of contrast enhanced magnetic resonance imaging using carbohydrate particles |
US5217998A (en) * | 1985-07-02 | 1993-06-08 | Biomedical Frontiers, Inc. | Composition for the stabilization of deferoxamine to chelate free ions in physiological fluid |
US4795698A (en) * | 1985-10-04 | 1989-01-03 | Immunicon Corporation | Magnetic-polymer particles |
US5336762A (en) * | 1985-11-18 | 1994-08-09 | Access Pharmaceuticals, Inc. | Polychelating agents for image and spectral enhancement (and spectral shift) |
DE3688613T2 (de) * | 1985-11-18 | 1994-01-13 | Access Pharma Inc | Polychelierende stoffe für abbildung- und spektralerhöhung (und spektrale verschiebung). |
US5554386A (en) * | 1986-07-03 | 1996-09-10 | Advanced Magnetics, Inc. | Delivery of therapeutic agents to receptors using polysaccharides |
US4951675A (en) * | 1986-07-03 | 1990-08-28 | Advanced Magnetics, Incorporated | Biodegradable superparamagnetic metal oxides as contrast agents for MR imaging |
US5219554A (en) | 1986-07-03 | 1993-06-15 | Advanced Magnetics, Inc. | Hydrated biodegradable superparamagnetic metal oxides |
US5336506A (en) * | 1986-07-03 | 1994-08-09 | Advanced Magnetics Inc. | Targeting of therapeutic agents using polysaccharides |
US4770183A (en) * | 1986-07-03 | 1988-09-13 | Advanced Magnetics Incorporated | Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents |
US5342607A (en) * | 1986-07-03 | 1994-08-30 | Advanced Magnetics, Inc. | Receptor mediated endocytosis type magnetic resonance imaging contrast agents |
US5352432A (en) * | 1986-07-03 | 1994-10-04 | Advanced Magnetics, Inc. | Hepatocyte specific composition and their use as diagnostic imaging agents |
US5679323A (en) * | 1986-07-03 | 1997-10-21 | Advanced Magnetics, Inc. | Hepatocyte-specific receptor-mediated endocytosis-type compositions |
US5284646A (en) * | 1986-07-03 | 1994-02-08 | Advanced Magnetics Inc. | Hepatocyte specific receptor mediated endocytosis type magnetic resonance imaging contrast agents |
US5141739A (en) * | 1986-07-03 | 1992-08-25 | Advanced Magnetics, Inc. | Delivery of x-ray contrast agents using receptor mediated endocytosis |
US5672334A (en) * | 1991-01-16 | 1997-09-30 | Access Pharmaceuticals, Inc. | Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans |
DE3640708C2 (de) * | 1986-11-28 | 1995-05-18 | Schering Ag | Verbesserte metallhaltige Pharmazeutika |
FI80801C (fi) * | 1987-01-14 | 1990-07-10 | Innofarm Oy | Konjugat av en monoklonal antikropp och anvaendning. eller ett fragment daerav och ett kelaterande aemne, dess framstaellning |
DE3709851A1 (de) * | 1987-03-24 | 1988-10-06 | Silica Gel Gmbh Adsorptions Te | Nmr-diagnostische fluessigkeitszusammensetzungen |
DE3710730A1 (de) * | 1987-03-31 | 1988-10-20 | Schering Ag | Substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel |
DE3728525A1 (de) * | 1987-08-24 | 1989-03-16 | Schering Ag | Mehrkernige substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel |
GB8801646D0 (en) * | 1988-01-26 | 1988-02-24 | Nycomed As | Chemical compounds |
US5681543A (en) * | 1988-02-29 | 1997-10-28 | Shering Aktiengesellschaft | Polymer-bonded complexing agents and pharmaceutical agents containing them for MRI |
GB8813144D0 (en) * | 1988-06-03 | 1988-07-06 | Nycomed As | Compositions |
GB8813425D0 (en) * | 1988-06-07 | 1988-07-13 | Hall L D | Magnetic resonance imaging |
WO1990001295A1 (en) | 1988-08-04 | 1990-02-22 | Advanced Magnetics, Incorporated | Receptor mediated endocytosis type mri contrast agents |
US5213788A (en) * | 1988-09-29 | 1993-05-25 | Ranney David F | Physically and chemically stabilized polyatomic clusters for magnetic resonance image and spectral enhancement |
EP0361960A3 (de) * | 1988-09-29 | 1992-01-02 | RANNEY, David F. | Verfahren und Vorrichtung zur Bilderzeugung mittels magnetischer Resonanz |
US5260050A (en) * | 1988-09-29 | 1993-11-09 | Ranney David F | Methods and compositions for magnetic resonance imaging comprising superparamagnetic ferromagnetically coupled chromium complexes |
US5314681A (en) * | 1988-12-23 | 1994-05-24 | Nycomed Innovation Ab | Composition of positive and negative contrast agents for electron spin resonance enhanced magnetic resonance imaging |
US5364613A (en) * | 1989-04-07 | 1994-11-15 | Sieving Paul F | Polychelants containing macrocyclic chelant moieties |
US5914095A (en) * | 1989-04-07 | 1999-06-22 | Salutar, Inc. | Polychelants containg amide bonds |
GB8916781D0 (en) * | 1989-07-21 | 1989-09-06 | Nycomed As | Compositions |
US5393525A (en) * | 1989-07-21 | 1995-02-28 | Nycomed Imaging As | Contrast medium comprising superparamagnetic or ferromagnetic particles capable of increasing viscosity after administration |
GB8916782D0 (en) * | 1989-07-21 | 1989-09-06 | Nycomed As | Compositions |
GB8916780D0 (en) * | 1989-07-21 | 1989-09-06 | Nycomed As | Compositions |
JP2726520B2 (ja) * | 1989-10-20 | 1998-03-11 | 名糖産業株式会社 | 有機磁性複合体 |
GB8923843D0 (en) * | 1989-10-23 | 1989-12-13 | Salutar Inc | Compounds |
US5446145A (en) * | 1990-01-19 | 1995-08-29 | Nycomed Salutar, Inc. | Polychelant compounds |
US5679810A (en) * | 1990-01-19 | 1997-10-21 | Salutar, Inc. | Linear oligomeric polychelant compounds |
US5236694A (en) * | 1990-02-21 | 1993-08-17 | The Board Of Regents, The University Of Texas System | 19f labelled dextrans and antibodies as nmr imaging and spectroscopy agents |
US5494655A (en) * | 1990-03-09 | 1996-02-27 | The Regents Of The University Of California | Methods for detecting blood perfusion variations by magnetic resonance imaging |
US5190744A (en) * | 1990-03-09 | 1993-03-02 | Salutar | Methods for detecting blood perfusion variations by magnetic resonance imaging |
US5368840A (en) * | 1990-04-10 | 1994-11-29 | Imarx Pharmaceutical Corp. | Natural polymers as contrast media for magnetic resonance imaging |
US5358702A (en) * | 1990-04-10 | 1994-10-25 | Unger Evan C | Methoxylated gel particle contrast media for improved diagnostic imaging |
US5420176A (en) * | 1990-06-01 | 1995-05-30 | Imarx Pharmaceutical Corp. | Contrast media for ultrasonic imaging |
US5268165A (en) * | 1990-10-16 | 1993-12-07 | Biomedical Frontiers, Inc. | Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging |
US5236693A (en) * | 1990-11-14 | 1993-08-17 | Brigham And Women's Hospital | Medical ultrasound contrast agent and method of using same |
US5143716A (en) * | 1991-02-01 | 1992-09-01 | Unger Evan C | Phosphorylated sugar alcohols, Mono- and Di-Saccharides as contrast agents for use in magnetic resonance imaging of the gastrointestinal region |
US5885549A (en) * | 1991-02-01 | 1999-03-23 | Imarx Pharmaceutical Corp. | Phosphorylated materials as contrast agents for use in magnetic resonance imaging of the gastrointestinal region |
GB9106686D0 (en) * | 1991-03-28 | 1991-05-15 | Hafslund Nycomed As | Improvements in or relating to contrast agents |
US5310539A (en) * | 1991-04-15 | 1994-05-10 | Board Of Regents, The University Of Texas System | Melanin-based agents for image enhancement |
DE4115789A1 (de) * | 1991-05-10 | 1992-11-12 | Schering Ag | Makrocyclische polymer-komplexbildner, deren komplexe, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
DK0543020T3 (da) * | 1991-06-11 | 1998-08-31 | Oxideret sammensætning indeholdende vandopløseligtcarboxypolysaccharid og magnetisk jernoxid | |
JP2901787B2 (ja) * | 1991-07-15 | 1999-06-07 | 日本メジフィジックス株式会社 | 核磁気共鳴造影剤 |
JP2894879B2 (ja) * | 1991-10-04 | 1999-05-24 | 日本メジフィジックス株式会社 | 診断用造影剤 |
US5480990A (en) * | 1991-12-10 | 1996-01-02 | The Dow Chemical Company | Bicyclopolyazamacrocyclocarboxylic acid complexes for use as contrast agents |
US5739294A (en) * | 1991-12-10 | 1998-04-14 | The Dow Chemical Company | Bicyclopol yazamacrocyclophosphonic acid complexes for use as contrast agents |
GB9200388D0 (en) * | 1992-01-09 | 1992-02-26 | Nycomed As | Improvements in or relating to contrast agents |
US5514379A (en) * | 1992-08-07 | 1996-05-07 | The General Hospital Corporation | Hydrogel compositions and methods of use |
US5691423A (en) * | 1992-08-24 | 1997-11-25 | The United States Of America As Represented By The Department Of Health And Human Services | Polysaccharide-bound nitric oxide-nucleophile adducts |
AU5355094A (en) * | 1992-10-14 | 1994-05-09 | Sterling Winthrop Inc. | Therapeutic and diagnostic imaging compositions and methods |
US5817292A (en) * | 1992-10-14 | 1998-10-06 | Nycomed Imaging As | MR imaging compositions and methods |
AU5323794A (en) * | 1992-10-14 | 1994-05-09 | Sterling Winthrop Inc. | Chelating polymers |
US5532006A (en) * | 1993-04-23 | 1996-07-02 | The Board Of Trustees Of The University Of Illinois | Magnetic gels which change volume in response to voltage changes for MRI |
NL9302163A (nl) * | 1993-12-10 | 1995-07-03 | Univ Delft Tech | Gecarboxymethyleerde oligo- en polysacchariden als kristallisatie inhibitors. |
US6693190B1 (en) | 1994-05-11 | 2004-02-17 | Bracco International B.V. | Enhanced relaxivity monomeric and multimeric compounds |
ZA958789B (en) * | 1994-10-21 | 1996-05-29 | Nihon Mediphysics Co Ltd | Diagnostic imaging agent |
DE19629494A1 (de) * | 1996-07-09 | 1998-01-15 | Schering Ag | Pseudopolyrotaxane |
NL1003776C2 (nl) * | 1996-08-09 | 1998-02-20 | Cooperatie Cosun U A | Milieuvriendelijke complexanten voor zware metalen |
NL1007320C2 (nl) * | 1997-10-20 | 1999-04-21 | Cooperatie Cosun U A | Milieuvriendelijke complexanten voor zware metalen. |
JP2001523693A (ja) * | 1997-11-20 | 2001-11-27 | ディヴィッド プラット | 腫瘍の治療及び/又は映像化剤 |
US6113880A (en) * | 1997-12-17 | 2000-09-05 | Schering Aktiengesellschaft | Polyrotaxane derivatives for x-ray and nuclear magnetic resonance imaging |
DE19808079A1 (de) * | 1998-02-20 | 1999-08-26 | Schering Ag | Hydroxyethylstärke-Konjugate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel |
US6896874B2 (en) * | 1998-05-26 | 2005-05-24 | Wisconsin Alumni Research Foundation | MR-signal emitting coatings |
US6361759B1 (en) | 1998-05-26 | 2002-03-26 | Wisconsin Alumni Research Foundation | MR signal-emitting coatings |
US5980863A (en) * | 1998-11-02 | 1999-11-09 | Eagle Vision Pharmaceutical Corporation | Manganese compositions and methods for MRI |
EP1031354A3 (de) | 1999-01-19 | 2003-02-05 | Rohm And Haas Company | Polymere MRI Kontrastmittel |
US7871597B2 (en) | 1999-04-09 | 2011-01-18 | Amag Pharmaceuticals, Inc. | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents |
JP4056701B2 (ja) | 1999-05-14 | 2008-03-05 | ザ レジェンツ オブ ザ ユニヴァースティ オブ カリフォルニア | 薬剤および診断薬の送達のための高分子担体 |
US20040253292A1 (en) * | 2003-04-23 | 2004-12-16 | Wisconsin Alumni Research Foundation | MR-signal emitting coatings |
JP2008531755A (ja) * | 2005-01-05 | 2008-08-14 | ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システム | 二重画像化および放射線化学療法のためのコンジュゲート:組成物、製造および適応 |
WO2006124726A2 (en) | 2005-05-12 | 2006-11-23 | The General Hospital Corporation | Novel biotinylated compositions |
US7527601B2 (en) * | 2005-12-29 | 2009-05-05 | Intrapartum Ventures, Llc | Cervimeter |
US7811239B2 (en) * | 2005-12-29 | 2010-10-12 | Intrapartum, Llc | Cervical dilation measurement apparatus |
US7713216B2 (en) * | 2006-04-10 | 2010-05-11 | Intrapartum, Llc | Method for cervical dilation and/or measurement |
US20070156042A1 (en) * | 2005-12-30 | 2007-07-05 | Orhan Unal | Medical device system and method for tracking and visualizing a medical device system under MR guidance |
US8457712B2 (en) * | 2005-12-30 | 2013-06-04 | Wisconsin Alumni Research Foundation | Multi-mode medical device system and methods of manufacturing and using same |
US8532742B2 (en) * | 2006-11-15 | 2013-09-10 | Wisconsin Alumni Research Foundation | System and method for simultaneous 3DPR device tracking and imaging under MR-guidance for therapeutic endovascular interventions |
US20080183070A1 (en) * | 2007-01-29 | 2008-07-31 | Wisconsin Alumni Research Foundation | Multi-mode medical device system with thermal ablation capability and methods of using same |
US8412306B2 (en) * | 2007-02-28 | 2013-04-02 | Wisconsin Alumni Research Foundation | Voltage standing wave suppression for MR-guided therapeutic interventions |
US10996218B2 (en) | 2008-03-11 | 2021-05-04 | Ournextbaby Llc | Methods for chemotaxis / redox driven separation of X and Y chromosome bearing sperm and their insemination in gender specific menstrual cycles |
US20100196272A1 (en) | 2009-01-30 | 2010-08-05 | Neoprobe Corporation | Compositions for radiolabeling diethylenetriaminepentaacetic acid (dtpa)-dextran |
KR101059285B1 (ko) * | 2009-05-07 | 2011-08-24 | 가톨릭대학교 산학협력단 | 가돌리늄 착물, 그 제조방법, 및 그것을 포함하는 mri 조영제 |
WO2012036691A1 (en) | 2010-09-16 | 2012-03-22 | Urobiologics Llc | Use of female mammal's urine for determination of fetal gender related characteristics |
EP2838564A4 (de) * | 2012-04-19 | 2015-12-02 | Purdue Research Foundation | Hochverzweigte alpha-d-glucane |
WO2014036427A1 (en) | 2012-08-31 | 2014-03-06 | The General Hospital Corporation | Biotin complexes for treatment and diagnosis of alzheimer's disease |
WO2021172030A1 (ja) * | 2020-02-28 | 2021-09-02 | 国立大学法人九州大学 | 組成物、動的核偏極用組成物、高偏極化組成物、物質の高偏極化方法、高偏極化した物質およびnmr測定方法 |
WO2022020659A1 (en) * | 2020-07-23 | 2022-01-27 | Purdue Research Foundation | Ohpp-formulated niclosamide to treat sars-cov-2, other viral diseases, and cancers |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2862920A (en) * | 1956-06-07 | 1958-12-02 | Ohio Commw Eng Co | Ferrous carboxymethyl dextran |
GB1175834A (en) * | 1966-04-07 | 1969-12-23 | Atomic Energy Authority Uk | Improvements in or relating to the Chemical Production of Metal-Containing Materials as Particles and other Configurations |
US3563978A (en) * | 1968-05-15 | 1971-02-16 | Irving L Ochs | Polyvalent metal complexes of natural polymers |
US3928581A (en) * | 1972-09-13 | 1975-12-23 | Astra Laekemedel Ab | Certain polymer-iron complexes for treatment of iron deficiency |
SE431214B (sv) * | 1977-06-02 | 1984-01-23 | Klaus H Mosbach | Sett att framstella magnetiska polymerpartiklar som berare av en foretredesvis biologiskt aktiv substans |
US4370476A (en) * | 1979-07-17 | 1983-01-25 | Usher Thomas C | Dextran polycarboxylic acids, ferric hydroxide complexes |
DE3129906C3 (de) * | 1981-07-24 | 1996-12-19 | Schering Ag | Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik |
US4452773A (en) * | 1982-04-05 | 1984-06-05 | Canadian Patents And Development Limited | Magnetic iron-dextran microspheres |
US4731239A (en) * | 1983-01-10 | 1988-03-15 | Gordon Robert T | Method for enhancing NMR imaging; and diagnostic use |
WO1984002643A1 (en) * | 1983-01-10 | 1984-07-19 | Robert Thomas Gordon | Method for enhancing nmr imaging; and diagnostic use |
NL194579C (nl) * | 1983-01-21 | 2002-08-05 | Schering Ag | Diagnostisch middel. |
US4423158A (en) * | 1983-01-27 | 1983-12-27 | Gelinnovation Handelsaktiebolag | Ion adsorbent for metals having a coordination number greater than two |
CA1242643A (en) * | 1983-08-12 | 1988-10-04 | Eric T. Fossel | Nmr imaging utilizing chemical shift reagents |
FR2550449B1 (fr) * | 1983-08-12 | 1986-01-31 | Commissariat Energie Atomique | Agents de relaxation specifiques d'organes ou de pathologies, utilisables pour modifier les contrastes en imagerie medicale par resonance magnetique nucleaire |
CA1243602A (en) * | 1983-08-25 | 1988-10-25 | Hong-Ning Yeung | Methods for enhancing the contrast in nmr imaging |
US4615879A (en) * | 1983-11-14 | 1986-10-07 | Vanderbilt University | Particulate NMR contrast agents for gastrointestinal application |
SE463651B (sv) * | 1983-12-21 | 1991-01-07 | Nycomed As | Diagnostikum och kontrastmedel |
US4728575A (en) * | 1984-04-27 | 1988-03-01 | Vestar, Inc. | Contrast agents for NMR imaging |
GB8413849D0 (en) * | 1984-05-31 | 1984-07-04 | Amersham Int Plc | Nmr contrast agents |
US4675173A (en) * | 1985-05-08 | 1987-06-23 | Molecular Biosystems, Inc. | Method of magnetic resonance imaging of the liver and spleen |
US4822594A (en) * | 1987-01-27 | 1989-04-18 | Gibby Wendell A | Contrast enhancing agents for magnetic resonance images |
-
1984
- 1984-11-01 SE SE8405499A patent/SE465907B/sv not_active IP Right Cessation
-
1985
- 1985-10-25 EP EP85307737A patent/EP0186947B1/de not_active Expired - Lifetime
- 1985-10-25 DE DE8585307737T patent/DE3578647D1/de not_active Expired - Fee Related
- 1985-10-25 AT AT85307737T patent/ATE54416T1/de not_active IP Right Cessation
- 1985-10-31 NO NO854348A patent/NO168928C/no unknown
- 1985-10-31 DK DK499985A patent/DK167998B1/da active
- 1985-11-01 US US06/793,898 patent/US4986980A/en not_active Expired - Lifetime
- 1985-11-01 JP JP60244239A patent/JPH0667854B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE54416T1 (de) | 1990-07-15 |
SE8405499D0 (sv) | 1984-11-01 |
JPH0667854B2 (ja) | 1994-08-31 |
EP0186947A1 (de) | 1986-07-09 |
US4986980A (en) | 1991-01-22 |
DK167998B1 (da) | 1994-01-17 |
JPS61155337A (ja) | 1986-07-15 |
NO854348L (no) | 1986-05-02 |
SE8405499L (sv) | 1986-05-02 |
EP0186947B1 (de) | 1990-07-11 |
SE465907B (sv) | 1991-11-18 |
DK499985A (da) | 1986-05-02 |
NO168928C (no) | 1992-04-22 |
NO168928B (no) | 1992-01-13 |
DK499985D0 (da) | 1985-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3578647D1 (de) | Paramagnetische kontrastmittel fuer die anwendung in "in vivo" nmr-diagnostischen methoden und die herstellung davon. | |
DE3577185D1 (de) | Paramagnetische kontrastmittel fuer die anwendung in "in vivo" nmr-diagnostischen methoden und die herstellung davon. | |
DE69006565T2 (de) | Tampon, insbesondere für die weibliche Hygiene, Verfahren und Vorrichtung für dessen Herstellung. | |
EP0397652A4 (en) | Water insoluble derivatives of hyaluronic acid | |
DE69025920T2 (de) | Glykosaminoglykan-modifiertes Protein, Verfahren zu dessen Herstellung und pharmazeutische Zubereitungen, die es enthalten | |
DE3855525T2 (de) | Verwendung eines Protein gebundenen Polysaccharid Zur Herstellung eines Arzneimittels für die Behandlung von AIDS. | |
DE69023957D1 (de) | Sulfatierte Polysaccharide, Antikoagulierungs- und Antikomplementärmittel, hergestellt aus Fukanen aus braunen Algen, und Verfahren zu deren Herstellung. | |
DE69531613D1 (de) | Einführung einer thiol-gruppe in proteine für die radioimmundetektion und radioimmuntherapie auf der basis von radionukliden | |
DE69011985T2 (de) | Medizinisches Material, Verfahren zu seiner Herstellung und medizinisches Gerät, in dem dieses Material verwendet wird. | |
CA2070647A1 (en) | Use of an anticoagulant as a diagnostic agent | |
DE3850778T2 (de) | Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks. | |
ATE168695T1 (de) | Glycosyl-etoposid-prodrugs, verfahren zu ihrer herstellung und ihre anwendung in kombination mit funktionalisierten tumorspezifischen enzym- konjugaten | |
HUT56286A (en) | Vaccine against swine cholera and diagnostic examination | |
DE69003960T2 (de) | Die Verwendung von deacetyliertem Chitin zur Herstellung eines Medikamentes für die Behandlung von entzündliche Krankheiten. | |
ATE17954T1 (de) | Mutastein, physiologisch wirksamer stoff und verfahren zu dessen herstellung. | |
WO1992005278A3 (en) | Method for the determination of the differential expression of mrna for the amyloid precursor protein (app) | |
DE69013726T2 (de) | Verbessertes Verfahren für die Herstellung von o-Carboxypyridyl- und o-Carboxychinolylimidazolinonen. | |
ATE60778T1 (de) | Oligosaccharide, verfahren zu ihrer herstellung und ihre anwendung. | |
FR2742336B1 (fr) | Collyre destine notamment au traitement de l'oeil sec | |
SE8405500L (sv) | Diagnosticeringspartiklar | |
EP0371733A3 (de) | Dopamin-beta-hydroxylase-Inhibitoren | |
ATE52032T1 (de) | Paramagnetische kontrastmittel fuer die anwendung in ''in vivo'' nmr-diagnostischen methoden und die herstellung davon. | |
DE58904502D1 (de) | Halterung fuer medizinische instrumente, insbesondere katheter, sowie verfahren zu deren herstellung. | |
JPS517113A (de) | ||
DE69031409D1 (de) | 8-Carboxy-1,2,3,4-tetrahydroquinolin-6-yl-essigsäure und Verfahren zu dessen Herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |